he still owns a huge % of the company, the announcement did have some good comments tho... don't know how far to read into them?!
" comes at an opportune time with the publication process of the US Clinical Trial results now at an imminent conclusion, with Adrian observing that the summarised abstract’s conclusions were “the best outcome we could have hoped for… [and] supports our view that Mente can bring substantial change to the management of ASD."
Ann: Board Change, page-3
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
